Ultrasound-Guided Hip Injections with High Density Hyaluronic Acid: Outcome at One Year Follow Up

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 May 11

PMID 38731044

Authors

Antonino Giulio Battaglia

Rocco DApolito

Fabio Labionda

Joil Ramazzotti

Luigi Zagra

Affiliations

Soon will be listed here.

Abstract

: The ultrasound-guided viscosupplementation of the hip joint with hyaluronic acid (HA) is considered a standard procedure among the conservative treatments for hip arthritis. The aim of this study was to evaluate the clinical benefit and the incidence of adverse events of the technique in an observational study at one year follow up. We evaluated a consecutive series of 85 patients with a diagnosis of symptomatic arthritis who underwent intra-articular ultrasound-guided hyaluronic acid injections. The scales used for evaluation were modified Harris Hip Score (mHHS), WOMAC (Western Ontario and McMaster University), and Hip Outcome Score (HOS) with subscale Sport (HOSs), for pain the Visual Analogic Scale (VAS). The patients were classified according to Tonnis' radiological classification of arthritis (range 0-3): 20 patients (grade 0), 32 (grade 1), 18 (grade 2), 15 (grade 3). At last follow up, all the scales increased: mHHS from 59.35 to 82.1, HOS from 69.45 to 78.53, HOss from 47.4 to 58.11, VAS from 6.09 to 3.97, WOMAC from 33.2 to 31.5 ( < 0.05 for all the parameters); the results were elaborated with GraphPad Prism v5.0 (Prism Software La Jolla, CA, USA) using Wilcoxon's test. A total of 13 patients out of 85 needed arthroplasty, all classified as Tonnis grade 3. No serious adverse events were noted due to the procedure. Based on our findings, indication for the use of hyaluronic acid is limited to patients with mild to moderate arthritis. Patients in advanced arthritis refusing replacement surgery and asking for this treatment should be informed about the poor results of the technique even in the short term.

References

Eymard F, Maillet B, Lellouche H, Mellac-Ducamp S, Brocq O, Loeuille D . Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. BMC Musculoskelet Disord. 2017; 18(1):3. PMC: 5217257. DOI: 10.1186/s12891-016-1359-2. View

Terkawi A, Karakitsos D, Elbarbary M, Blaivas M, Durieux M . Ultrasound for the anesthesiologists: present and future. ScientificWorldJournal. 2013; 2013:683685. PMC: 3856172. DOI: 10.1155/2013/683685. View

Rastogi A, Davis K, Ross A, Rosas H . Fundamentals of Joint Injection. AJR Am J Roentgenol. 2016; 207(3):484-94. DOI: 10.2214/AJR.16.16243. View

Lim J, Chou A, Yeo W, Lo N, Chia S, Chin P . Comparison of patient quality of life scores and satisfaction after common orthopedic surgical interventions. Eur J Orthop Surg Traumatol. 2015; 25(6):1007-12. DOI: 10.1007/s00590-015-1635-0. View

Nouri F, Babaee M, Peydayesh P, Esmaily H, Raeissadat S . Comparison between the effects of ultrasound guided intra-articular injections of platelet-rich plasma (PRP), high molecular weight hyaluronic acid, and their combination in hip osteoarthritis: a randomized clinical trial. BMC Musculoskelet Disord. 2022; 23(1):856. PMC: 9464606. DOI: 10.1186/s12891-022-05787-8. View

Dodre E, Lefebvre G, Cockenpot E, Chastanet P, Cotten A . Interventional MSK procedures: the hip. Br J Radiol. 2015; 89(1057):20150408. PMC: 4985956. DOI: 10.1259/bjr.20150408. View

Murphy L, Helmick C . The impact of osteoarthritis in the United States: a population-health perspective: A population-based review of the fourth most common cause of hospitalization in U.S. adults. Orthop Nurs. 2012; 31(2):85-91. DOI: 10.1097/NOR.0b013e31824fcd42. View

Wilson M, Michet Jr C, Ilstrup D, Melton 3rd L . Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study. Mayo Clin Proc. 1990; 65(9):1214-21. DOI: 10.1016/s0025-6196(12)62745-1. View

Migliore A, Bella A, Bisignani M, Calderaro M, De Amicis D, Logroscino G . Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study. Clin Rheumatol. 2012; 31(8):1187-96. DOI: 10.1007/s10067-012-1994-4. View

10.

Wu B, Li Y, Liu Y . Efficacy of intra-articular hyaluronic acid injections in hip osteoarthritis: a meta-analysis of randomized controlled trials. Oncotarget. 2017; 8(49):86865-86876. PMC: 5689731. DOI: 10.18632/oncotarget.20995. View

11.

Narouze S . Ultrasound-guided interventional procedures in pain management: Evidence-based medicine. Reg Anesth Pain Med. 2010; 35(2 Suppl):S55-8. DOI: 10.1097/AAP.0b013e3181d24658. View

12.

Micu M, Micu A, Bolboaca S . Ultrasound-guided injection with hyaluronic acid in hip osteoarthritis: efficacy and safety in a real-life setting. Clin Rheumatol. 2022; 41(8):2491-2498. DOI: 10.1007/s10067-022-06154-7. View

13.

LEVEAUX V, QUIN C . Local injection of hydrocortisone and procaine in osteo-arthritis of the hip joint. Ann Rheum Dis. 1956; 15(4):330-7. PMC: 1006905. DOI: 10.1136/ard.15.4.330. View

14.

Hoeber S, Aly A, Ashworth N, Rajasekaran S . Ultrasound-guided hip joint injections are more accurate than landmark-guided injections: a systematic review and meta-analysis. Br J Sports Med. 2015; 50(7):392-6. DOI: 10.1136/bjsports-2014-094570. View

15.

Lawrence R, Helmick C, Arnett F, Deyo R, Felson D, Giannini E . Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998; 41(5):778-99. DOI: 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V. View

16.

Balazs E, Denlinger J . Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993; 39:3-9. View

17.

Clementi D, DAmbrosi R, Bertocco P, Bucci M, Cardile C, Ragni P . Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol. 2017; 28(5):915-922. DOI: 10.1007/s00590-017-2083-9. View

18.

Crowe H . Osteo-arthritis of the Hip-joint treated by Intra-articular Injections. Proc R Soc Med. 2009; 40(9):486-7. PMC: 2183591. View

19.

Moss A, Murphy L, Helmick C, Schwartz T, Barbour K, Renner J . Annual incidence rates of hip symptoms and three hip OA outcomes from a U.S. population-based cohort study: the Johnston County Osteoarthritis Project. Osteoarthritis Cartilage. 2016; 24(9):1518-27. PMC: 5466003. DOI: 10.1016/j.joca.2016.04.012. View

20.

Iagnocco A . Imaging the joint in osteoarthritis: a place for ultrasound?. Best Pract Res Clin Rheumatol. 2010; 24(1):27-38. DOI: 10.1016/j.berh.2009.08.012. View